We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more Rheumatology | Oxford Academic Skip to Main Content
Impact Factor
5 year Impact Factor

J M van Laar

Editorial Board

About Rheumatology

An international journal publishing the highest quality scientific papers on a wide range of paediatric and adult rheumatological and musculoskeletal conditions.

Find out more

Editor's Choice

Each month Editor Jaap van Laar picks a noteworthy article from the current issue to be made freely available online.

Browse the collection


Find out the latest from Rheumatology in our interactive infographic, and access free content from across the journal.


Global news and updates

Read rheumatology news snippets from around the world, including EMA drug updates, new or revised guidelines, and professional and regulatory updates.

Explore the interactive map


RA patient access to DMARDs in Norway

Dr James Galloway and Dr Samantha Hider, Keele University, UK discuss a paper by Polina Putrik et al. which looked at access to DMARDs. They discuss the findings of the paper which demonstrated that older patients with low levels of education have less access to DMARDs. They also explore the possible implications of these findings on the daily practice of rheumatologists and the importance of looking at health literacy of patients in practice. 

Listen to the podcast | Read the related article

Treating IgG4-related disease with rituximab

Dr James Galloway and Dr Justin Mason, Imperial College London, UK discuss a paper published in the Journal by John Stone et al. who looked at patients with IgG4 related disease treated with rituximab, to determine if there were potential markers to predict relapse in patients after treatment. They discuss the potential implications for future treatment, drawbacks of the study and possible future research directions for the disease. 

Listen to the podcast | Read the related article

BSR Guidelines on axial spondyloarthritis

Dr James Galloway and Dr Louise Hamilton, Norfolk and Norwich University Hospital, UK discuss the key findings of the updated BSR guidelines on axial spondyloarthritis and recommendations for treatment. They highlight the importance of considering extra-articular manifestations in treatment and the possibility of switching treatment if anti-TNF treatment fails.

Listen to the podcast | Read the related article

Free editorials

All editorials published in Rheumatology are freely available online.  

Browse editorials


Guidelines are key to modern health and practice. Discover the current BSR guidelines on a wide range of topics.


Register for alerts

Never miss an issue. Receive table of contents email alerts as soon as each issue is published online.

Sign up

BSR Membership

The British Society for Rheumatology exists to support you and help you care for your patients.

Join us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Subscribe Now